Web-enabled module manifests
Research workspace · registry aware
Cancer Research Platform
A pipeline-guided workspace for molecular characterization, evidence exchange, and reproducible research reporting.
Cancer Discovery Pipeline
Seven-stage research framework- Data
- Molecular state
- Biomarkers
- Vulnerabilities
- Pharmacology
- Validation
- Report
Overview
A guided research journey, grounded in registry state.
Registered modules describe intended contracts. Completed results appear only after a validated release and its artifact envelopes enter the catalog.
Current readiness
What the catalog supports today
Referenced dataset contracts
Immutable release records
Published artifact envelopes
Registered modules
Scientific modules remain independently versioned.
The interface presents a connected journey while preserving each manifest contract.
- 01P001 · v0.3.0active
Molecular State Explorer
Research-only molecular-state modeling project with independently versioned task contracts. T001 includes metadata and read-only compatibility validation for the completed legacy TCGA-BRCA TP53 candidate. The current platform specification remains unapproved and cannot pass G0 or produce a release.
- Declared inputs
- 0
- Declared outputs
- 3
- Dataset references
- 3
- 02P002 · v0.1.0scaffold
Cancer Vulnerability Explorer
Contract scaffold for integrating molecular-state evidence with functional, pharmacological, and proteomic evidence to evaluate candidate vulnerabilities. No vulnerability analysis or validation is implemented.
- Declared inputs
- 2
- Declared outputs
- 4
- Dataset references
- 5
Evidence boundary
Results begin with immutable records.
Awaiting registry records
No research outputs are published
The current manifests are scaffolds. The workspace will not display biomarkers, vulnerabilities, scores, reports, or completion claims until release records exist.